Stay updated on Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The website revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T12:32:36.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Layout/UI updates were observed on the Study Details page. Core study information such as eligibility criteria, outcomes, and locations remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-28T05:59:29.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page footer, representing a minor version bump with no other visible changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T15:37:16.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page shows revision history updated from v3.4.0 to v3.4.1, with no visible changes to study details, layout, or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:16:10.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T10:36:13.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The Locations section now lists a large set of new site locations across the United States, Canada, the United Kingdom, Australia, India, and other regions, replacing the prior shorter listing with a more expansive directory. This broadens where the study is conducted and how potential participants can locate a site.
    Difference
    2%
    Check dated 2025-12-23T21:20:57.000Z thumbnail image

Stay in the know with updates to Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.